What is the first thing you imagine when thinking about climate change? Usually, our mind jumps to the dramatic images – melting glaciers, rising sea levels, and extreme weather events. It’s all true. These are the visible, large-scale effects that grab our attention. However, there’s also another side to this story, one that’s equally important yet often overlooked: the impact on the microscopic world of microorganisms, including bacteria, viruses, fungi, so the unseen majority. They are everywhere – in the air, soil, water, and even inside our bodies. Thus, such global changes as climate change, shifting ecosystems, or the rise of drug-resistant pathogens have profound impact on microbiology and infection biology.
By recognizing and addressing these effects, we can better protect our health. And the 7th Joint Microbiology & Infection Conference of the German Society for Hygiene and Microbiology (DGHM) and the Association for General and Applied Microbiology (VAAM) offered a unique platform for this. From June 2nd to 5th, our Fujifilm Wako Chemicals Europe team met with internationally renowned speakers and young scientists in Würzburg to exchange information on current developments in diagnostics and clinical practice in microbiology.
This year, we were excited to showcase our innovative invasive fungal infection diagnostic system LIMUSAVE MT-7500. It is a state-of-the-art system for measuring the pan-fungal biomarker beta-D-Glucan. This device has 10 measuring stations and can be expanded to 30. This means it can flexibly handle a low to high volume of tests simultaneously. More to that, LIMUSAVE MT-7500 measures the analyte quantitatively by a single test procedure, allowing for immediate and simple on-site testing by labs at medical centers.
Find out more about the LIMUSAVE MT-7500 here.